265 related articles for article (PubMed ID: 32089234)
1. Seaweed-derived bioactives as potential energy regulators in obesity and type 2 diabetes.
Bermano G; Stoyanova T; Hennequart F; Wainwright CL
Adv Pharmacol; 2020; 87():205-256. PubMed ID: 32089234
[TBL] [Abstract][Full Text] [Related]
2. Potential Bioactive Compounds from Seaweed for Diabetes Management.
Sharifuddin Y; Chin YX; Lim PE; Phang SM
Mar Drugs; 2015 Aug; 13(8):5447-91. PubMed ID: 26308010
[TBL] [Abstract][Full Text] [Related]
3. The role of seaweed bioactives in the control of digestion: implications for obesity treatments.
Chater PI; Wilcox MD; Houghton D; Pearson JP
Food Funct; 2015 Nov; 6(11):3420-7. PubMed ID: 26416783
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
5. Roles of Marine Macroalgae or Seaweeds and Their Bioactive Compounds in Combating Overweight, Obesity and Diabetes: A Comprehensive Review.
Magwaza SN; Islam MS
Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103396
[TBL] [Abstract][Full Text] [Related]
6. Phenolic Bioactives From Plant-Based Foods for Glycemic Control.
Sarkar D; Christopher A; Shetty K
Front Endocrinol (Lausanne); 2021; 12():727503. PubMed ID: 35116002
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic Potential of Marine Brown Algae-a Mini Review.
Gunathilaka TL; Samarakoon K; Ranasinghe P; Peiris LDC
J Diabetes Res; 2020; 2020():1230218. PubMed ID: 32377517
[TBL] [Abstract][Full Text] [Related]
8. Uses of Papaya Leaf and Seaweed Supplementations for Controlling Glucose Homeostasis in Diabetes.
Nyakundi BB; Yang J
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047820
[TBL] [Abstract][Full Text] [Related]
9. Seaweeds-derived compounds modulating effects on signal transduction pathways: A systematic review.
Juárez-Portilla C; Olivares-Bañuelos T; Molina-Jiménez T; Sánchez-Salcedo JA; Moral DID; Meza-Menchaca T; Flores-Muñoz M; López-Franco Ó; Roldán-Roldán G; Ortega A; Zepeda RC
Phytomedicine; 2019 Oct; 63():153016. PubMed ID: 31325683
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic potential of seaweed and their bioactive compounds: a review of developments in last decade.
Agarwal S; Singh V; Chauhan K
Crit Rev Food Sci Nutr; 2023; 63(22):5739-5770. PubMed ID: 35048763
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
12. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect of Seaweed Derived Xanthophyl Carotenoid on Obesity Management; Overview of the Last Decade.
Ojulari OV; Lee SG; Nam JO
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260306
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity and anti-diabetic bioactive peptides: A comprehensive review of their sources, properties, and techno-functional challenges.
Joshua Ashaolu T; Joshua Olatunji O; Can Karaca A; Lee CC; Mahdi Jafari S
Food Res Int; 2024 Jul; 187():114427. PubMed ID: 38763677
[TBL] [Abstract][Full Text] [Related]
15. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus.
Zhao C; Yang C; Wai STC; Zhang Y; P Portillo M; Paoli P; Wu Y; San Cheang W; Liu B; Carpéné C; Xiao J; Cao H
Crit Rev Food Sci Nutr; 2019; 59(6):830-847. PubMed ID: 30501400
[TBL] [Abstract][Full Text] [Related]
17. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
18. Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties.
Admassu H; Gasmalla MAA; Yang R; Zhao W
J Food Sci; 2018 Jan; 83(1):6-16. PubMed ID: 29227526
[TBL] [Abstract][Full Text] [Related]
19. FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity.
Benchoula K; Arya A; Parhar IS; Hwa WE
Eur J Pharmacol; 2021 Jan; 891():173758. PubMed ID: 33249079
[TBL] [Abstract][Full Text] [Related]
20. Shared signaling pathways and targeted therapy by natural bioactive compounds for obesity and type 2 diabetes.
Tian S; Zhao H; Song H
Crit Rev Food Sci Nutr; 2024; 64(15):5039-5056. PubMed ID: 36397728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
